20 20 Biolabs Inc (AIDX)

Finanzdaten der 20 20 Biolabs Inc-Aktie (AIDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Revenues	106.74%0.73	0.35
Cost Of Revenue	46.59%0.43	0.29
Gross Profit	384.59%0.30	0.06
	2.84%1.55	1.51
Selling, General, and Administrative	4.54%1.29	1.35
Research and Development	67.86%0.26	0.15
Operating Income/Loss	13.80%-1.24	-1.44
Nonoperating Income/Loss	64.17%-0.26	-0.73
	30.74%-1.51	-2.17
Attributable To Parent	30.74%-1.51	-2.17
Available To Common Stockholders, Basic	29.80%-2.75	-2.12
Preferred Stock Dividends And Other Adjustments	324.50%0.12	-0.05
Basic Average Shares	40.92%10.79	7.66
Diluted Average Shares	40.92%10.79	7.66
Basic Earnings Per Share	7.14%-0.26	-0.28
Diluted Earnings Per Share	7.14%-0.26	-0.28